These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 26147002)

  • 1. 14-3-3 Binding and Sumoylation Concur to the Down-Modulation of β-catenin Antagonist chibby 1 in Chronic Myeloid Leukemia.
    Mancini M; Leo E; Takemaru K; Campi V; Castagnetti F; Soverini S; De Benedittis C; Rosti G; Cavo M; Santucci MA; Martinelli G
    PLoS One; 2015; 10(7):e0131074. PubMed ID: 26147002
    [TBL] [Abstract][Full Text] [Related]  

  • 2. DNA methyltransferase 1 drives transcriptional down-modulation of β catenin antagonist Chibby1 associated with the BCR-ABL1 gene of chronic myeloid leukemia.
    Leo E; Mancini M; Castagnetti F; Gugliotta G; Santucci MA; Martinelli G
    J Cell Biochem; 2015 Apr; 116(4):589-97. PubMed ID: 25389112
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Chibby 1: a new component of β-catenin-signaling in chronic myeloid leukemia.
    Mancini M; Soverini S; Gugliotta G; Santucci MA; Rosti G; Cavo M; Martinelli G; Castagnetti F
    Oncotarget; 2017 Oct; 8(50):88244-88250. PubMed ID: 29152155
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BCR-ABL1-associated reduction of beta catenin antagonist Chibby1 in chronic myeloid leukemia.
    Leo E; Mancini M; Aluigi M; Luatti S; Castagnetti F; Testoni N; Soverini S; Santucci MA; Martinelli G
    PLoS One; 2013; 8(12):e81425. PubMed ID: 24339928
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyper-activation of Aurora kinase a-polo-like kinase 1-FOXM1 axis promotes chronic myeloid leukemia resistance to tyrosine kinase inhibitors.
    Mancini M; De Santis S; Monaldi C; Bavaro L; Martelli M; Castagnetti F; Gugliotta G; Rosti G; Santucci MA; Martinelli G; Cavo M; Soverini S
    J Exp Clin Cancer Res; 2019 May; 38(1):216. PubMed ID: 31122263
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chibby drives β catenin cytoplasmic accumulation leading to activation of the unfolded protein response in BCR-ABL1+ cells.
    Mancini M; Leo E; Takemaru K; Campi V; Borsi E; Castagnetti F; Gugliotta G; Santucci MA; Martinelli G
    Cell Signal; 2013 Sep; 25(9):1820-7. PubMed ID: 23707389
    [TBL] [Abstract][Full Text] [Related]  

  • 7. RAD 001 (everolimus) prevents mTOR and Akt late re-activation in response to imatinib in chronic myeloid leukemia.
    Mancini M; Petta S; Martinelli G; Barbieri E; Santucci MA
    J Cell Biochem; 2010 Feb; 109(2):320-8. PubMed ID: 20014066
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Downregulation of γ-catenin inhibits CML cell growth and potentiates the response of CML cells to imatinib through β-catenin inhibition.
    Niu CC; Zhao C; Yang ZD; Zhang XL; Wu WR; Pan J; Zhao C; Li ZQ; Ding W; Yang Z; Si WK
    Int J Mol Med; 2013 Feb; 31(2):453-8. PubMed ID: 23233089
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Deregulation of the Wilms' tumour gene 1 protein (WT1) by BCR/ABL1 mediates resistance to imatinib in human leukaemia cells.
    Svensson E; Vidovic K; Lassen C; Richter J; Olofsson T; Fioretos T; Gullberg U
    Leukemia; 2007 Dec; 21(12):2485-94. PubMed ID: 17728783
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Regulative Loop between β-catenin and Protein Tyrosine Receptor Type γ in Chronic Myeloid Leukemia.
    Tomasello L; Vezzalini M; Boni C; Bonifacio M; Scaffidi L; Yassin M; Al-Dewik N; Takam Kamga P; Krampera M; Sorio C
    Int J Mol Sci; 2020 Mar; 21(7):. PubMed ID: 32225105
    [TBL] [Abstract][Full Text] [Related]  

  • 11. FOXM1 Transcription Factor: A New Component of Chronic Myeloid Leukemia Stem Cell Proliferation Advantage.
    Mancini M; Castagnetti F; Soverini S; Leo E; De Benedittis C; Gugliotta G; Rosti G; Bavaro L; De Santis S; Monaldi C; Martelli M; Santucci MA; Cavo M; Martinelli G
    J Cell Biochem; 2017 Nov; 118(11):3968-3975. PubMed ID: 28401599
    [TBL] [Abstract][Full Text] [Related]  

  • 12. ApoptomiRs expression modulated by BCR-ABL is linked to CML progression and imatinib resistance.
    Ferreira AF; Moura LG; Tojal I; Ambrósio L; Pinto-Simões B; Hamerschlak N; Calin GA; Ivan C; Covas DT; Kashima S; Castro FA
    Blood Cells Mol Dis; 2014; 53(1-2):47-55. PubMed ID: 24629639
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differences in BCL-X(L) expression and STAT5 phosphorylation in chronic myeloid leukaemia patients.
    Gutiérrez-Castellanos S; Cruz M; Rabelo L; Godínez R; Reyes-Maldonado E; Riebeling-Navarro C
    Eur J Haematol; 2004 Apr; 72(4):231-8. PubMed ID: 15089759
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Chk2 drives late G1/early S phase arrest of clonal myeloid progenitors expressing the p210 BCR-ABL tyrosine kinase in response to STI571.
    Mazzacurati L; Pattacini L; Brusa G; Mancini M; Benvenuti M; Barbieri E; Martinelli G; Baccarani M; Greenberger JS; Santucci MA
    Hematol J; 2004; 5(2):168-77. PubMed ID: 15048068
    [TBL] [Abstract][Full Text] [Related]  

  • 15. IRF5 is a target of BCR-ABL kinase activity and reduces CML cell proliferation.
    Massimino M; Consoli ML; Mesuraca M; Stagno F; Tirrò E; Stella S; Pennisi MS; Romano C; Buffa P; Bond HM; Morrone G; Sciacca L; Di Raimondo F; Manzella L; Vigneri P
    Carcinogenesis; 2014 May; 35(5):1132-43. PubMed ID: 24445143
    [TBL] [Abstract][Full Text] [Related]  

  • 16. 14-3-3 ligand prevents nuclear import of c-ABL protein in chronic myeloid leukemia.
    Mancini M; Veljkovic N; Corradi V; Zuffa E; Corrado P; Pagnotta E; Martinelli G; Barbieri E; Santucci MA
    Traffic; 2009 Jun; 10(6):637-47. PubMed ID: 19220809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A calpain-cleaved fragment of β-catenin promotes BCRABL1+ cell survival evoked by autophagy induction in response to imatinib.
    Mancini M; Leo E; Campi V; Castagnetti F; Zazzeroni L; Gugliotta G; Santucci MA; Martinelli G
    Cell Signal; 2014 Aug; 26(8):1690-7. PubMed ID: 24747551
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Zinc-finger transcription factor slug contributes to the survival advantage of chronic myeloid leukemia cells.
    Mancini M; Petta S; Iacobucci I; Salvestrini V; Barbieri E; Santucci MA
    Cell Signal; 2010 Aug; 22(8):1247-53. PubMed ID: 20388540
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Role of Dok-1 and Dok-2 in myeloid homeostasis and suppression of leukemia.
    Yasuda T; Shirakata M; Iwama A; Ishii A; Ebihara Y; Osawa M; Honda K; Shinohara H; Sudo K; Tsuji K; Nakauchi H; Iwakura Y; Hirai H; Oda H; Yamamoto T; Yamanashi Y
    J Exp Med; 2004 Dec; 200(12):1681-7. PubMed ID: 15611294
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anti-cancer fatty-acid derivative induces autophagic cell death through modulation of PKM isoform expression profile mediated by bcr-abl in chronic myeloid leukemia.
    Shinohara H; Taniguchi K; Kumazaki M; Yamada N; Ito Y; Otsuki Y; Uno B; Hayakawa F; Minami Y; Naoe T; Akao Y
    Cancer Lett; 2015 Apr; 360(1):28-38. PubMed ID: 25644089
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.